Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psoriasis and cancer.

S Shuster, P H Chapman, M D Rawlins

    British Medical Journal
    |April 7, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Patients with psoriasis may have a lower risk of skin cancer due to impaired arylhydrocarbon hydroxylase (AHH) activity in their skin, potentially reducing carcinogen metabolism. This finding suggests psoriasis might offer a genetic advantage against certain cancers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Three Cases of Snake-Bite and Antivenene.

    The Indian medical gazette·2017
    Same author

    Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.

    British journal of clinical pharmacology·2015
    Same author

    A comparative study of methyldopa and labetalol in the treatment of hypertension.

    British journal of clinical pharmacology·2015
    Same author

    Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapy.

    British journal of clinical pharmacology·2015
    Same author

    A multicentre open trial of labetalol in New Zealand.

    British journal of clinical pharmacology·2015
    Same author

    Spontaneous reporting of fatal adverse drug reactions.

    The International journal of risk & safety in medicine·2013
    Same journal

    Muscular pain during therapy with carbenoxolone (Biogastrone).

    British medical journal·2016
    Same journal

    ACUTE INTESTINAL OBSTRUCTION DUE TO INTRA-ABDOMINAL CAUSES.

    British medical journal·2014
    Same journal

    A CASE OF HAEMATIDROSIS.

    British medical journal·2014
    Same journal

    Incidence of ulcer in haematemesis.

    British medical journal·2011
    Same journal

    Pituitary hypothyroidism with impaired renal function.

    British medical journal·2011
    Same journal

    The fenestration operation for otosclerosis.

    British medical journal·2011
    See all related articles

    Area of Science:

    • Dermatology
    • Oncology
    • Biochemistry

    Background:

    • Psoriasis patients treated with known carcinogens show a surprisingly low incidence of skin cancer.
    • This observation challenges conventional understanding of carcinogen exposure and cancer development.

    Purpose of the Study:

    • To investigate the hypothesis that impaired arylhydrocarbon hydroxylase (AHH) activity in psoriatic skin reduces carcinogen metabolism.
    • To explore the potential implications of this impaired activity for cancer incidence in psoriasis patients.

    Main Methods:

    • The study proposes a hypothesis based on existing observations rather than new experimental data.
    • It focuses on the biochemical pathway involving arylhydrocarbon hydroxylase (AHH) activity.

    Main Results:

    Related Experiment Videos

    • A reduced capacity of psoriatic skin to metabolize precarcinogens is hypothesized, linked to impaired AHH activity.
    • If this holds true for other tissues, psoriasis patients might exhibit reduced cancer incidence from environmental carcinogens.

    Conclusions:

    • Impaired AHH activity in psoriasis could confer a protective genetic advantage against certain cancers.
    • This speculative hypothesis warrants further investigation into the genetic and biochemical underpinnings of psoriasis and cancer risk.